Arch Venture Management’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-381,249
| Closed | -$7.82M | – | 10 |
|
|
2024
Q1 | $7.82M | Hold |
381,249
| – | – | 9.75% | 4 |
|
|
2023
Q4 | $8.18M | Sell |
381,249
-312,500
| -45% | -$6.71M | 5% | 4 |
|
|
2023
Q3 | $14.3M | Hold |
693,749
| – | – | 9.3% | 4 |
|
|
2023
Q2 | $20.5M | Sell |
693,749
-1,875,000
| -73% | -$55.3M | 12.64% | 4 |
|
|
2023
Q1 | $59.2M | Sell |
2,568,749
-1,100,000
| -30% | -$25.3M | 28.57% | 2 |
|
|
2022
Q4 | $102M | Hold |
3,668,749
| – | – | 26.13% | 1 |
|
|
2022
Q3 | $113M | Sell |
3,668,749
-1,500,000
| -29% | -$46M | 14.6% | 3 |
|
|
2022
Q2 | $152M | Buy |
+5,168,749
| New | +$152M | 18.54% | 3 |
|